was successfully added to your cart.

Your SEO optimized title page contents

Marihuana for Medical Purposes Regulations

Quantum 9 Canada MMPR

The waiting is the hardest part of the Marihuana for Medical Purposes Regulations program.

As the months continue to come and go, those who have applied to become a licensed producer in Canada are now becoming increasingly worried about the status of their application. Health Canada’s most recent numbers indicate that they have received over 1,000 applications. Only two new applicants have been awarded licenses over the last 100 days. Many of these groups have spent hundreds of thousands of dollars already preparing facilities, training staff members, and writing company policies and standard operating procedures.

While Health Canada has rejected over 200 applications already, many are still waiting, and fearing the worst. Health Canada, this time around, seems to be doing their due diligence when it comes to vetting and qualifying applicants. Many groups that have not received the dreaded rejection letter have instead received requests for more information. The requests from the Minister are typically opportunities for applicants to provide more details on important topics such as quality assurance, security, or shipping methods.

Although some are losing patience, others are still confident that Health Canada will continue to accept applications for quite some time. However, due to the large amount of already existing applications in the queue, it’s uncertain how many will ultimately be awarded with one of the few licenses.

If you’re interested in making your application stand out among the rest, reach out to Quantum 9 today.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply